☰ Category

Inflammatory Bowel Disease Update


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days


Check Your Delivery Options

Product Out of Stock Subscription

(Notify me when this product is back in stock)

Rs. 4,396

Availability: Out of stock

  • Product Description

IBD is a lifelong disease with periods of active disease alternating with periods of remission. IBD is thought to result from the interaction between genetic and environmental factors that influence the normal intestinal commensal flora to trigger an inappropriate mucosal immune response. Colonoscopy remains the gold stander for diagnosis of IBD. Wireless capsule endoscope and balloon enteroscopy show many advances in diagnosis of IBD. CT and MRI help to detect extent of disease and assess complications. Serological and fecal markers alone can not establish diagnosis of IBD but they have only a prognostic value. 5-ASA agents are the mainstay in the treatment of both CD and UC. Steroids continue to be the first choice to treat active disease. 6-mercaptopurine and azathioprine are steroid-sparing immunomodulators effective in the maintenance of remission of both CD and UC while methotrexate may be used in both induction and maintenance of CD. Infliximab and adalimumab are anti-TNF agents approved for the treatment of CD and UC. Other new emerging therapies include antibiotics, prebiotics, probiotics, leucocyte apheresis, Interferon-alpha and helminth.

Product Specifications
SKU :COC26474
Authorahmed sharaf
Number of Pages152
Publishing Year2012-03-01T00:00:00.000
Edition1 st
Book TypeMedicine
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-07-29 00:00:00
0 Review(s)